Wire flash
U.S. government to announce most-favored-nation drug pricing for Medicaid in all 50 states
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
According to U.S. financial media outlet Semafor, as reported by Chinese financial data platform Jin10, the U.S. government is preparing to announce that all 50 states will adopt most-favored-nation (MFN) pricing for certain drugs within Medicaid programs. This policy would tie the prices paid by Medicaid for specific medications to the lowest prices available in other developed countries, aiming to reduce drug costs for the government program. The announcement is expected to be made by the U.S. government, though the exact timing and the list of drugs affected were not specified in the report. The implementation across all states represents a significant expansion of drug pricing controls in the U.S. healthcare system.
Source report
According to U.S. financial media outlet Semafor, the U.S. government is set to announce that all 50 states will implement most-favored-nation pricing for certain drugs in Medicaid programs.
Source
金十数据Neutral / independent
Part of this Story
Trump announces most-favored-nation drug pricing for all 50 state Medicaid programs